Rovi stock at EUR 58.90 ahead of Wednesday’s Xetra open
Published on 10/21/2026 at 07:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSFinancial results date ahead
- Rovi operates as a pharmaceutical laboratory focused on products and health-related activities.
- Rovi lists its first nine months 2026 financial results for November 5, 2026.
- Rovi stock trades pre-market at EUR 58.90 at 7:58 a.m. CEST at Lang & Schwarz on October 21, 2026.
Rovi operates as a pharmaceutical laboratory with activities covering pharmaceutical products and the health field, according to the company’s investor-relations website. Rovi stock trades pre-market at EUR 58.90 at 7:58 a.m. CEST at Lang & Schwarz on October 21, 2026.
Ahead of the Xetra open
The pre-market indication is being monitored ahead of the Xetra session. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Rovi stock.
Rovi’s business and calendar
ROVI develops and manufactures pharmaceutical products and operates in the health sector, as described on its investor-relations website. The company’s calendar lists the first nine months 2026 financial results for November 5, 2026. Market context: Market report IBEX 35.
Disclaimer...
en | ES0157261019 | ROVI | boerse | 70379665 | bgmi
